The concept of social exclusion/inclusion figured prominently in the policy discourse in France in the mid 1970s. The concept was later adopted by the European Union in the late 1980s as a key concept in social policy and in many instances replaced the concept of poverty. This concept which had first appeared in Europe as a response to the crisis of the welfare State has now gained considerable currency over the last five years in both official and development discourses in Nepal. The issue gained considerable leverage when the Nepal Government recognized inclusion as a policy issue as one of the four pillars of 2003 Poverty Reduction Strategy Paper (PRSP), which is also Nepal's Tenth Plan. The debates surrounding inclusion/exclusion have ascended to conspicuous importance in the present political transition in Nepal with several groups such as Dalit, women, ethnic communities, donor communities, Madhesi communities and region voicing their demands for an inclusive state by virtue of which, the issue has now come to be a part of the popular public discourse. However, what has to be borne in mind is that the concept lacks universality in the way it has been defined and employed. While some claim that social exclusion is more illuminating and holds the promise of understanding disadvantaged groups better, others argue that this concept is so evocative, ambiguous, multidimensional and elastic that it can be defined in many different ways and owing to its ambiguity in definition it may mean all things to all people. Howsoever, the term has been used, defined, conceptualized, the article here makes an effort to review accessible literature on the topic.DOI = 10.3126/dsaj.v2i0.1362Dhaulagiri Journal of Sociology and Anthropology Vol.2 pp.161-180

BackgroundBuilding appropriate levels of trust in pharmaceuticals is a painstaking and challenging task, involving participants from different spheres of life, including producers, distributors, retailers, prescribers, patients and the mass media. Increasingly, however, trust is not just a national matter, but involves cross-border flows of knowledge, threats and promises.MethodsData for this paper comes from the project 'Tracing Pharmaceuticals in South Asia', which used ethnographic fieldwork and qualitative interviews to compared the trajectories of three pharmaceuticals (Rifampicin, Oxytocin and Fluoxetine) from producer to patient in three sites (north India, West Bengal and Nepal) between 2005-08.ResultsWe argue that issues of trust are crucial in reducing the likelihood of appropriate use of medicines. Unlike earlier discussions of trust, we suggest that trust contexts beyond the patient-practitioner relationship are important. We illustrate these arguments through three case studies: (i) a conflict over ethics in Nepal, involving a suggested revised ethical code for retailers, medical representatives, producers and prescribers; (ii) disputes over counterfeit, fake, substandard and spurious medicines, and quality standards in Indian generic companies, looking particularly at the role played by the US FDA; and (iii) the implications of lack of trust in the DOTS programmes in India and Nepal for the relationships among patients, government and the private sector.ConclusionsWe conclude that the building of trust is a necessary but always vulnerable and contingent process. While it might be desirable to outline steps that can be taken to build trust, the range of conflicting interests in the pharmaceutical field make feasible solutions hard to implement.

Nutrient use efficiency is crucial for increasing crop yield and quality while reducing fertilizer inputs and minimizing environmental damage. The experiments were carried out in silty clay loam soil of Lalitpur, Nepal, to examine how different amounts of nitrogen (N), phosphorus (P), and potassium (K) influenced crop performance and nutrient efficiency indices in wheat during 2019/20 and 2020/21. The field experiment comprised three factorial randomized complete block designs that were replicated three times. N levels (100, 125, 150 N kg ha-1), P levels (25, 50, 75 P2O5 kg ha-1), and K levels (25, 50, 75 K2O kg ha-1) were three factors evaluated, with a total of 27 treatment combinations. Grain yields were significantly increased by N and K levels and were optimum @ 125 kg N ha-1 and @ 50 kg K2O ha-1 with grain yields of 6.33 t ha-1 and 6.30 t ha-1, respectively. Nutrient levels influenced statistically partial factor productivity, internal efficiency, partial nutrient budget, recovery efficiency, agronomic efficiency, and physiological efficiency of NPK for wheat. Nutrient efficiency was found to be higher at lower doses of their respective nutrients. Higher P and K fertilizer rates enhanced wheat N efficiencies, and the case was relevant for P and K efficiencies as well. Wheat was more responsive to N and K fertilizer, and a lower rate of P application reduced N and K fertilizer efficiency. This study recommends to use N @ 125 kg ha-1, P2O5 @ 25 kg ha-1 and K2O @ 50 kg ha-1 as an optimum rate for efficient nutrient management in wheat in mid-hills of Nepal.

Abstract-